Establishment of company was settled on 8th of October,2010 as an independent company from Y'sTherapeutics Co., Ltd., with an aim to develop the cancer therapy by a humanized monoclonal antibody against CD26 molecule(YS110) which is expressing on a..
Relevance: 7.4301186